Last week, the European Medicines Agency's (:EMA) Committee for Medicinal Products for Human Use (CHMP) provided a positive opinion on the approval of DuoResp Spiromax inhalation powder. Teva is ...
JERUSALEM--(BUSINESS WIRE)--Apr. 29, 2014-- Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) announced today that the European Commission has granted marketing authorization for DuoResp Spiromax® for ...
Teva Receives CHMP Positive Opinion for DuoResp® Spiromax® for the Treatment of Patients Diagnosed with Asthma and COPD in Europe JERUSALEM--(BUSINESS WIRE)--Feb. 21, 2014-- Teva Pharmaceutical ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DUORESP SPIROMAX contains two active ingredients in one inhaler: ...
DuoResp Spiromax ® inhaler has won silver at the 2015 Medical Design Excellence Awards (MDEA). The awards recognize significant advances in medical product design ...
Teva Pharmaceuticals Europe B.V., (NYSE and TASE: TEVA) today ...
DuoResp Spiromax ® inhaler has won silver at the 2015 Medical Design Excellence Awards (MDEA). The awards recognize significant advances in medical product design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results